Atomoxetine for the treatment of pediatric nocturnal enuresis

Jess P Shatkin1

  • 1Western Psychiatric Institute and Clinic, University of Pittsburgh School of Medicine, Pittsburgh, PA 15213, USA. shatkinjp@upmc.edu

Insights

Four children with attention deficit hyperactivity disorder (ADHD) and nocturnal enuresis found their bedwetting resolved when treated with atomoxetine for ADHD. This medication offers a potential new avenue for treating comorbid ADHD and enuresis.

Area of Science:

  • Pediatric medicine
  • Neurology
  • Psychiatry

Background:

  • Current treatments for pediatric nocturnal enuresis include behavioral methods and medications like antidiuretic hormone analogs, tricyclic antidepressants, and anticholinergics.
  • A significant portion of children do not fully respond to existing enuresis treatments, even with optimal management.
  • Attention deficit hyperactivity disorder (ADHD) is a common comorbidity in children with nocturnal enuresis.

Observation:

  • This report details four pediatric cases with comorbid ADHD and nocturnal enuresis.
  • Each child received atomoxetine for their ADHD symptoms.
  • A notable observation was the unexpected resolution of nocturnal enuresis in all four patients following atomoxetine treatment.

Findings:

  • Atomoxetine, a medication primarily used for ADHD, demonstrated a serendipitous positive effect on nocturnal enuresis.
  • The resolution of enuresis occurred in children who were treated for ADHD with atomoxetine.
  • This suggests a potential link between ADHD treatment and enuresis improvement.

Implications:

  • Atomoxetine may represent a novel therapeutic option for children experiencing both ADHD and nocturnal enuresis.
  • Further research is warranted to explore the efficacy and mechanisms of atomoxetine in treating comorbid ADHD and enuresis.
  • This finding could lead to improved management strategies for children with complex neurodevelopmental and urological conditions.

Related Concept Videos

Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Management of Insomnia01:19

Management of Insomnia

The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
The Micturition Reflex01:26

The Micturition Reflex

Urination, or micturition involves the coordination of the bladder's detrusor muscle and two sphincters to ensure controlled bladder emptying.
The process begins with bladder filling, where the bladder wall stretches as urine accumulates. This stretching activates the urine storage reflex, mediated by the sacral spinal segments and the pontine storage center. Efferent sympathetic impulses stimulate the detrusor muscle to relax and the internal urethral sphincter to contract, facilitating urine...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Substance Use Disorders Affecting Sleep01:24

Substance Use Disorders Affecting Sleep

Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...